首页> 外文期刊>BMC Health Services Research >Comparison of medicine availability measurements at health facilities: evidence from Service Provision Assessment surveys in five sub-Saharan African countries
【24h】

Comparison of medicine availability measurements at health facilities: evidence from Service Provision Assessment surveys in five sub-Saharan African countries

机译:卫生机构的可用药物量度比较:来自五个撒哈拉以南非洲国家的服务提供评估调查的证据

获取原文
           

摘要

Background With growing emphasis on health systems strengthening in global health, various health facility assessment methods have been used increasingly to measure medicine and commodity availability. However, few studies have systematically compared estimates of availability based on different definitions. The objective of this study was to compare estimates of medicine availability based on different definitions. Methods A secondary data analysis was conducted using data from the Service Provision Assessment (SPA) – a nationally representative sample survey of health facilities – conducted in five countries: Kenya SPA 2010, Namibia SPA 2009, Rwanda SPA 2007, Tanzania SPA 2006, and Uganda SPA 2007. For 32 medicines, percent of facilities having the medicine were estimated using five definitions: four for current availability and one for six-month period availability. ‘Observed availability of at least one valid unit’ was used as a reference definition, and ratios between the reference and each of the other four estimates were calculated. Summary statistics of the ratios among the 32 medicines were calculated by country. The ratios were compared further between public and non-public facilities within each country. Results Across five countries, compared to current observed availability of at least one valid unit, ‘reported availability without observation’ was on average 6% higher (ranging from 3% in Rwanda to 8% in Namibia), ‘observed availability where all units were valid’ was 11% lower (ranging from 2% in Tanzania to 19% in Uganda), and ‘six-month period availability’ was 14% lower (ranging from 5% in Namibia to 25% in Uganda). Conclusions Medicine availability estimates vary substantially across definitions, and need to be interpreted with careful consideration of the methods used.
机译:背景技术随着越来越多的人强调要加强全球卫生中的卫生系统,越来越多地使用了各种卫生设施评估方法来衡量药品和商品的可获得性。但是,很少有研究基于不同的定义来系统地比较可用性的估算。这项研究的目的是根据不同的定义比较药物可得性的估计。方法使用服务提供评估(SPA)的数据进行二次数据分析,SPA是全国代表性的卫生设施抽样调查,在五个国家进行:肯尼亚SPA 2010,纳米比亚SPA 2009,卢旺达SPA 2007,坦桑尼亚SPA 2006和乌干达。 SPA2007。对于32种药品,使用五个定义来估计拥有该药品的设施的百分比:四个定义为当前可用性,一个定义为六个月期间可用性。使用“观察到的至少一个有效单位的可用性”作为参考定义,并计算参考与其他四个估算值之间的比率。按国家计算了32种药物中比率的摘要统计数据。进一步比较了每个国家内公共和非公共设施之间的比率。结果在五个国家中,与当前观察到的至少一个有效单位的可用性相比,“未观察到的报告可用性”平均高出6%(从卢旺达的3%到纳米比亚的8%),有效期”降低了11%(从坦桑尼亚的2%降至乌干达的19%),“六个月有效期”降低了14%(从纳米比亚的5%降至乌干达的25%)。结论不同定义之间的药物可用性估计值存在很大差异,因此在解释时应仔细考虑所用方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号